Free Webex Call
United States hip replacement devices market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing demands for hip replacement surgeries. The rising geriatric population of the country and the rising prevalence of lower extremity conditions such as Osteoarthritis (OA), osteoporosis, and hip ailments are some of the major factors driving the growth of the United States hip replacement devices market in the upcoming five years. Consistent research and technological advancement in medical devices further support the growth of the United States hip replacement devices market in the next five years.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Hip replacement surgeries are the medical procedures where diseases or damaged parts of the hip joints are and installed implanted. The devices utilized for the surgical process of hip replacement are categorized as hip replacement devices and are further classified under primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices, and hip resurfacing devices. Incidences of accidents, stair falls, and sports events often lead to fractures or dislocation of the hip joints, other than diseases.
Orthopedic Surgeries Drive Market Growth
Rising instances of orthopedic surgeries majorly on the hip region are actively driving the growth of the United States hip replacement devices market in the upcoming five years. Advancing healthcare services and patient care adds to the surgical approaches toward hip replacement procedures. Also, growing cases of implants, and corrective devices that aid the orthopedic structure of the body further support the growth of the United States hip replacement devices market in the next five years.Increasing surgical ventures demand a higher count of expert surgeons functioning in the country. The healthcare system in the country provides well for the experts and the number of healthcare experts & workers has been rising rapidly in recent years, thus aiding the market growth. In the year 2021, there were 22,965 orthopedic surgeons in the country. More than 450,000 hip replacement surgeries are performed every year in the United States. Also, growing instances of diseases like osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, osteonecrosis, childhood arthritis in hips, etc. lead the market growth by aiding the demands for hip replacement surgeries.
Investments & Advancement Support Market Growth
The healthcare industry is well-established in the United States. It is one of the world’s best healthcare hubs that provides excellent healthcare services and patient care. Technologically advanced medical devices, high-tech healthcare infrastructure, and advanced medicine add to the potential growth of the industry along with the market. Higher expenses over healthcare services & patient care from the government, as well as the consumers, substantiates the growth of the United States hip replacement devices market in the upcoming five years.Market Segmentation
The United States hip replacement devices market is segmented by product type, end-user, competitional landscape, and regional distribution. Based on product type, the market is further fragmented into primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices, and hip resurfacing devices. By end user, the market is bifurcated into hospitals, ambulatory care centers, orthopedics clinics, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among the South region, Mid-West region, North-East region, and West region.Company Profile
Johnson & Johnson (DePuy Synthes), B. Braun Medical, Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Exactech, Inc., Conformis Inc., OMNIlife Science Inc., DJO Global, Inc., Medtronic USA, Inc., Aesculap Implant Systems, Inc., among others is a partial list of major market players of the companies responsible for the growth of United States hip replacement devices market.Report Scope:
In this report, United States hip replacement devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:United States Hip Replacement Devices Market, By Product Type:
- Primary Hip Reconstruction Devices
- Partial Hip Reconstruction Devices
- Revision Hip Reconstruction Devices
- Hip Resurfacing Devices
United States Hip Replacement Devices Market, By End User:
- Hospitals
- Ambulatory Care Centers
- Orthopedics Clinics
- Others
United States Hip Replacement Devices Market, By Region:
- South Region
- Mid-West Region
- North-East Region
- West Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in United States hip replacement devices market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview2. Research Methodology3. Impact of COVID-19 on United States Hip Replacement Devices Market4. Voice of Customer5. Executive Summary12. Market Trends & Developments13. Policy & Regulatory Landscape14. Import-Export Analysis15. United States Economic Profile17. Strategic Recommendations
6. United States Hip Replacement Devices Market Outlook
7. United States Primary Hip Reconstruction Devices Market Outlook
8. United States Partial Hip Reconstruction Devices Market Outlook
9. United States Revision Hip Reconstruction Devices Market Outlook
10. United States Hip Resurfacing Devices Market Outlook
11. Market Dynamics
16. Competitive Landscape
Companies Mentioned
- Johnson & Johnson (DePuy Synthes)
- B. Braun Medical, Inc.
- Stryker Corporation
- Zimmer Biomet Holdings Inc
- Exactech, Inc.
- Conformis Inc.
- OMNIlife Science Inc.
- DJO Global, Inc.
- Medtronic USA, Inc.
- Aesculap Implant Systems, Inc.